Trusted partner in life science

Innovating technologies
Accelerating global diagnostics

Strategic partnership with PhPlate Microplate Techniques AB in Sweden
23 March 2018
Nordic Biomed Innovation AB joined MOU with NAHDIC in Ethiopia
2 January 2018
Nordic Biomed Innovations AB joined MOU with JUNWON GBI Co., Ltd. in South Korea
7 February 2018
Nordic Biomed Innovation AB joined MOU with ALTEOGEN Inc. in South Korea
5 January 2018

Nordic Biomed Innovations AB

Based in Stockholm, Sweden, Nordic Biomed Innovations AB is a privately held life science company focused on identifying and introducing innovative technologies to the global diagnostics and biotechnology market.
We collaborate with scientific and industry partners to help transform promising ideas into real-world applications, providing tailored solutions to meet our clients’ needs.
isol-2

FEATURED TECHNOLOGY

This next-generation platform, developed by Biopromic AB (Sweden), integrates gold chemistry with magnetic separation to enable fast, stable, and versatile biomolecular conjugation across diagnostics and life science applications.

Key Advantages:

  • Strong, reliable bioconjugation
  • Fast and efficient workflows
  • High chemical and physical stability
  • Broad compatibility with diagnostic formats

Our Mission 1

Researching Innovations

We continuously explore groundbreaking ideas worldwide through our extensive global network.

Our Mission 2

R&D in Medical Diagnostics

We have collaborated with PhPlate Microplate AB in Stockholm, Sweden, to conduct R&D on diagnostic microbiology, developing innovative new solutions.

Our Mission 3

Product & Service Commercialization

We are dedicated to transforming innovations into effective market solutions through our extensive networks.

dsc_8043crop
Fast Facts

PhenePlate™

Description

The PhenePlate™ system is a user-friendly, cost-effective bacterial phenotyping kit designed for studying bacterial communities, including their diversity and stability in ecological research. Test results are automatically analyzed with PhPWIN™ software.

Target bacteria

E.coli
Other Enterobacteria
Aeromonas spp.
Vibrio spp.
Pseudomonas
Staphylococci
Enterococci
Bacilli
Lactobacili

Application

Epidemiological survey (Hospital-acquired infection)
Vaccine development
Environmental microbiology

NBI’s dedication to

Raise awareness of antibiotic resistance in society

RECENT NEWS

Request a Call Back

We can call you back

Complete our easy form to arrange a callback




    Emergency Call

    In case of urgent, feel free to ask questions.